Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in Japanese patients with Major Depressive Disorder
NCT01808612Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Mar 2013; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01808612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808612.